Detalhe da pesquisa
1.
[Multicenter evaluation of minimal residual disease monitoring in early induction therapy for treatment of childhood acute lymphoblastic leukemia].
Zhonghua Er Ke Za Zhi;
62(4): 337-344, 2024 Mar 25.
Artigo
em Chinês
| MEDLINE | ID: mdl-38527504